Legal Opinion
New York Ex Rel. Schneiderman v. Actavis PLC
Court of Appeals for the Second Circuit
Decided May 28, 2015No. 14-4624-cvPublishedCited by 228 opinions
1Opinion of the Court
JOHN M. WALKER, JR., Circuit Judge:
The State of New York brought this antitrust action against Defendanb-Appel-lant Actavis PLC and its wholly-owned subsidiary Forest Laboratories, LLC (collectively, “Defendants”). New York alleges that as Namenda IR, Defendants’ twice-daily drug designed to treat moderate-to-severe Alzheimer’s disease, neared the end of its patent exclusivity period in July 2015, Defendants introduced a new once-daily version called Namenda XR. The patents on XR ensure exclusivity, and thus prohibit generic versions of XR from entering the market, until 2029. Faced with the…
2Cases cited44 opinions
- United States v. United States Gypsum Co.Supreme Court of the United States · 1948
- United States v. Grinnell Corp.Supreme Court of the United States · 1966
- Standard Oil Company of New Jersey, Appts. v. United StatesSupreme Court of the United States · 1910
- Illinois Brick Co. v. IllinoisSupreme Court of the United States · 1977
- Precision Instrument Manufacturing Co. v. Automotive Maintenance MacHinery Co.Supreme Court of the United States · 1945
39 more not listed; retrieve them via the Exa API.
3Cited by228 opinions
- N. Am. Soccer League, LLC v. U.S. Soccer Fed'n, Inc.Court of Appeals for the Second Circuit · 2018
- United Food & Commercial Workers Unions v. Warner Chilcott Ltd. (In Re Asacol Antitrust Litig.)Court of Appeals for the First Circuit · 2018
- Yang v. KosinskiCourt of Appeals for the Second Circuit · 2020
- Campuzano v. Alavi FoundationCourt of Appeals for the Second Circuit · 2016
- JBR, Inc. v. Keurig Green Mountain, Inc.Court of Appeals for the Second Circuit · 2016
223 more not listed; retrieve them via the Exa API.